PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer
Status:
Recruiting
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and effectiveness of fimaporfin-induced photochemical
internalisation (PCI) of gemcitabine complemented by systemic gemcitabine/cisplatin
chemotherapy compared to gemcitabine/cisplatin alone, in patients with inoperable
cholangiocarcinoma (CCA). Participants will be randomly assigned to one of the treatment
groups and will receive study treatment for 6 months, followed by assessments every 3 months,
as applicable.